The world's first cancer vaccine has been shown to prevent melanoma reappearing in patients for as long as three years, researchers claim.

A long-standing trial into the mRNA-4157/V940 along with immunotherapy drugs produces results which potentially revolutionise cancer treatment.

The world's first cancer vaccine has been shown to prevent melanoma reappearing in patients for as long as three years, researchers claim.
A long-standing trial into the mRNA-4157/V940 along with immunotherapy drugs produces results which potentially revolutionise cancer treatment.

Gary Adshead will keep you up to date with all the latest breaking stories and issues on 6PR Mornings.

Gary Adshead will keep you up to date with all the latest breaking stories and issues on 6PR Mornings.

Advertisement